Evidence map›Paper›PMID 26677061›Full record

SynthesisMolecular medicine reports2016

Potential drawbacks in cell-assisted lipotransfer: A systematic review of existing reports (Review).

Sheng Huang, Weiliang Zhao, Zihua Wang, Kai Tao, Xiaoyan Liu, Peng Chang

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sheng HuangDepartment of Plastic and Reconstructive Surgery, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning 110840, P.R. China.
Weiliang ZhaoDepartment of Anesthesiology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Zihua WangDepartment of Plastic and Reconstructive Surgery, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning 110840, P.R. China.
Kai TaoDepartment of Plastic and Reconstructive Surgery, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning 110840, P.R. China.
Xiaoyan LiuDepartment of Plastic and Reconstructive Surgery, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning 110840, P.R. China.
Peng ChangDepartment of Plastic and Reconstructive Surgery, General Hospital of Shenyang Military Area Command, Shenyang, Liaoning 110840, P.R. China.
General Hospital of Shenyang Military Region · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-assisted lipotransfer (CAL) has been widely used in various clinical applications, including breast augmentation following mammectomy, soft-tissue reconstruction and wound healing. However, the clinical application of CAL has been restricted due to the transplanted fat tissues being readily liquefied and absorbed. The present review examines 57 previously published studies involving CAL, including fat grafting or fat transfer with human adipose-stem cells in all known databases. Of these 57 articles, seven reported the clinical application of CAL. In the 57 studies, the majority of the fat tissues were obtained from the abdomen via liposuction of the seven clinical studies, four were performed in patients requiring breast augmentation, one in a patient requiring facial augmentation, one in a patient requiring soft tissue augmentation/reconstruction and one in a patient requiring fat in their upper arms. Despite the potential risks, there has been an increased demand for CAL in in cosmetic or aesthetic applications. Thus, criteria and guidelines are necessary for the clinical application of CAL technology.

Indexed as

LipectomyAdipose TissueCell SeparationHumansPostoperative CareRisk FactorsStem Cells

Identifiers

PMID26677061
PMCPMC4732852
OpenAlexW2192356925

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.